tiprankstipranks
pc:axovi

Axovia Therapeutics

Axovia Therapeutics is a biotechnology company developing gene therapies to treat inherited retinal diseases. The company is advancing AXV-101, an investigational gene therapy targeting vision loss associated with Bardet-Biedl Syndrome 1 (BBS1), toward first-in-human clinical trials.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$1M
Total Amount Raised$1M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$1M
Latest Funding Amount$1M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 06, 2026
Investment
$1.10M

Investors

Investor Name
Funding Round

Related News and Analysis